SHENZHEN, China, 19. Juni 2023 /PRNewswire/ — Am 9. Juni fand das Summit Forum in Shenzhen über die Anwendung und den Bau von AGP in China unter der Leitung des National Innovation Centers für Fortgeschrittene Medizinische Geräte, das von China AGP and Digital Therapeutics R&D Center gesponsert wurde, statt. (nachstehend „F&E Center” genannt) und co-gesponsert von … Read more
SHENZHEN, China, 19 de junio de 2023 /PRNewswire/ — El 9 de junio tuvo lugar en Shenzhen el Foro de la Cumbre sobre la Aplicación y Construcción de AGP en China, dirigido por el Centro Nacional de Innovación de Dispositivos Médicos Avanzados, patrocinado por el Centro de I+D de AGP y Terapéutica Digital de China … Read more
AMSTERDAM, June 19, 2023 /PRNewswire/ — Freya Pharma Solutions, a pharmaceutical company dedicated to developing effective pharmaceutical therapies for women diagnosed with Female Sexual Disorders (FSD), announced today that the United States (US) Food and Drug Administration (FDA) has responded with interest and provided valuable input regarding Freya Pharma’s request for advice on the US Clinical … Read more
STOCKHOLM, June 19, 2023 /PRNewswire/ — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces today that the company’s patent application, covering both substance claims for fostroxacitabine bralpamide (fostrox) and its use for liver cancer treatment, has recently been approved by … Read more
First-Time Clinical Trial Outcomes Show Promising Follow-Up Results HANGZHOU, China, June 19, 2023 /PRNewswire/ — On May 17th, the 12-month results of the DRAGONFLY-DMR pivotal trial were presented at EuroPCR 2023. This trial was led by Professor Jian’an Wang from Zhe’er Hospital, Hangzhou, China, and presented on his behalf by the Eligibility Committee Chair, Professor … Read more
STOCKHOLM, June 19, 2023 /PRNewswire/ — During 13 June 2023 and 16 June 2023 Truecaller AB (publ) (LEI code 549300TEYF1FA5G5GK26) has repurchased in total 916,000 own B shares (ISIN: SE0016787071) as part of the share buyback programme initiated by the board of directors. The share buybacks form part of the share buyback programme announced by … Read more
SHENZHEN, China, June 19, 2023 /PRNewswire/ — On June 9, the Summit Forum on the Application and Construction of AGP in China, led by the National Innovation Center for Advanced Medical Devices, sponsored by China AGP and Digital Therapeutics R&D Center (hereafter referred to as the “R&D Center”), co-sponsored by Shenzhen SiBionics Technology Co., Ltd. (hereafter … Read more
STOCKHOLM, June 19, 2023 /PRNewswire/ — Beactica Therapeutics AB, the Swedish precision oncology company, today announced the appointment of Jarl Ulf Jungnelius M.D. to its Board of Directors. The appointment marks another step in Beactica’s strategic plan to become a clinical-stage company. Jarl Ulf Jungnelius M.D. is a licensed medical practitioner and a board-certified oncologist … Read more
STOCKHOLM, June 19, 2023 /PRNewswire/ — Beactica Therapeutics AB, the Swedish precision oncology company, today announced the appointment of Jarl Ulf Jungnelius M.D. to its Board of Directors. The appointment marks another step in Beactica’s strategic plan to become a clinical-stage company. Jarl Ulf Jungnelius M.D. is a licensed medical practitioner and a board-certified oncologist … Read more
NEW YORK, June 19, 2023 /PRNewswire/ — The global genomics market size is estimated to increase by USD 18,244.34 million from 2022 to 2027. The market’s growth momentum will progress at a CAGR of 10.53% during the forecast period. Discover some insights on market size historic period (2017 to 2021) and Forecast (2023 to 2027) before buying the … Read more